OGT and osteosarcoma: In osteosarcoma, pharmacological and genetic inhibitions of OGT lead to a reduction in DNA double-strand break repair mediated by RAD52-dependent homology recombination, ultimately resulting in cell cycle arrest and reduced cell proliferation (141).